← Leaderboards
Benjamin J Stein
University Of Chicago
$464,860
Attributed
$464,860
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $291.2K · FY2018–23$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$464,860 · 2
By mechanism
R15$342,076 · 1
F32$122,784 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Melissa Ellen Marks$149,034
- Jonathan W Willett$160,313
- Kristy Lynn Hentchel$24,360
- Norbert F Scherer$1,819,061
- Aaron Dinner$2,217,320
Others in their field
Other Emerging Leaders on “Antimicrobial”
- Urs Ochsner · Crestone, Inc.$23,443,941
- Ryan Cirz · Revagenix, Inc.$11,270,810
- Keith Kaye · University Of Michigan At Ann Arbor$11,130,173
- Nadine Georges Rouphael · Emory University$10,798,325
- Bruce Blough · Research Triangle Institute$8,559,012
- Sujatha Rashid · American Type Culture Collection$7,500,000
Research focus
AntimicrobialGenetic TranscriptionRegulationFutureComplexBiochemicalOrganismProteinsSignal TransductionCaulobacter CrescentusEnvironmentBacteriaAgricultureInfectionInsightGrowthHomeostasisIn VitroAffectGene ExpressionExperimental StudyCaulobacterGenesBiological
Grant awards (5)
Characterization of non-canonical regulatory pathways in the Caulobacter NtrYX signaling system$50,882
R15 · FY2023 · GM · contact PI
Characterization of non-canonical regulatory pathways in the Caulobacter NtrYX signaling system$155,832
R15 · FY2022 · GM · contact PI
Characterization of non-canonical regulatory pathways in the Caulobacter NtrYX signaling system$135,362
R15 · FY2022 · GM · contact PI
Elucidating the mechanism and sensory properties of a novel iron-sulfur binding histidine kinase inhibitor$63,746
F32 · FY2019 · GM · contact PI
Elucidating the mechanism and sensory properties of a novel iron-sulfur binding histidine kinase inhibitor$59,038
F32 · FY2018 · GM · contact PI